Furthermore, this concurrently facilitates the decrease in the anti‐tumor response of CD8+ T lymphocytes by augmenting their inhibitory signaling through PD‐1 receptors, producing an exhaustion and energy of T lymphocytes.76 The gene discussed is CD8A; the disease is neoplasm.